Le Lézard
Classified in: Science and technology, Business
Subjects: TDS, LIC, FVT

Nintex Drawloop DocGen and Adobe Sign Power Digital Document Workflows

BELLEVUE, Wash., Nov. 19, 2019 /PRNewswire/ -- Nintex, the global standard for process management and automation, today announced it has enhanced its integration between Nintex Drawloop DocGen® and Adobe Sign to support digital document workflows?the next major milestone in its partnership with Adobe. The new integration will make it faster and even easier for customer relationship management (CRM) customers to manage the entire lifecycle of their most mission-critical agreements.

Nintex is the global standard for process management and automation. Today more than 8,000 public and private sector clients across 90 countries turn to the Nintex Platform to accelerate their digital transformation journeys by enabling them to quickly and easily manage, automate and optimize business processes. Learn more at www.nintex.com. (PRNewsfoto/Nintex)

Customers across public and private sectors who leverage document automation capabilities from Nintex ? including Nintex Drawloop and Nintex Signtm powered by Adobe Sign, the only e-signature solution that supports digital document workflows and the Nintex Drawloop DocGen Lightning UI ? can further accelerate the creation, routing, execution, and storage of contracts, proposals, and other key documents while minimizing associated costs and risks and improving the experience of everyone involved in the sales cycle. Nintex Drawloop has been certified as a FedRAMP SaaS Compliant Cloud Service.

Adobe Sign brings even more benefits for customers ? a 420 percent ROI, according to a recent Forrester Research Total Economic Impact study.

"Nintex is committed to transforming the way people work through the automation of documents," said Nintex VP of Product Vincent Cabral. "By integrating Nintex Drawloop with Adobe Sign, we continue to improve the end-user experience, helping to drive bigger and better business results for customers. With simple clicks not code, Nintex Drawloop streamlines the digital document automation process by automatically preparing, sharing, and storing your most valuable documents where you need them."

"We're excited about this latest milestone between two best-in-class solutions that will make working with documents much faster and easier," said Adobe Director of Product Management Kelash Kumar. "Nintex Drawloop together with Adobe Sign will help Salesforce customers transform digital document workflows for their employees and their own customers."  

These latest digital document automation enhancements from Nintex and Adobe allow customers to automatically set default values, settings, and properties and to embed robust e-signature capabilities in documents using Nintex Drawloop DocGen, Nintex Drawloop DocAutomation, and Adobe Sign. Additionally, business users can instantly generate and route documents for execution with simple clicks from directly within their CRM system which reduces errors and eliminates the need for cutting and pasting.  

Nintex Drawloop is available on the AppExchange where customers may also download specific managed packages for government and public sector, and industries including financial services, health and life sciences and field service.

Nintex company representatives will be in San Francisco November 19-22 for Dreamforce 2019. To learn more visit, https://www.nintex.com/dreamforce-2019/.

Media Contact
Kristin Treat 
cell: +1 (215) 317-9091

About Nintex
Nintex is the global standard for process management and automation. Today more than 8,000 public and private sector clients across 90 countries turn to the Nintex Platform to accelerate progress on their digital transformation journeys by quickly and easily managing, automating and optimizing business processes. Learn more by visiting www.nintex.com and experience how Nintex and its global partner network are shaping the future of Intelligent Process Automation (IPA).

Product or service names mentioned herein may be the trademarks of their respective owners.


These press releases may also interest you

at 08:05
Axcella Health Inc. , a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, today announced mechanistic data for AXA4010 that are being presented...

at 08:00
Genius Central, founded in October 1999, is celebrating 20 years in business providing essential components of the supply chain to the natural and specialty grocery industry. Processing over $2 billion in orders annually, the company's mission to...

at 08:00
Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies, announced early data from its ongoing investigator initiated trial ("IIT") at...

at 07:55
AstraZeneca today presented results from the interim analysis of the Phase III ELEVATE TN trial, showing that CALQUENCE® (acalabrutinib) combined with obinutuzumab or as monotherapy significantly improved progression-free survival (PFS) compared to...

at 07:33
AbbVie , a research-based global biopharmaceutical company, today announced results from an extended follow-up analysis of the Phase 3 E1912 clinical study ? designed and conducted by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and sponsored by...

at 07:30
AbbVie , a research-based global biopharmaceutical company, today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) clinical trial,1 evaluating IMBRUVICA® (ibrutinib) in combination with VENCLEXTA®/VENCLYXTO® (venetoclax) in previously...

News published on 19 november 2019 at 08:59 and distributed by: